Nautilus Biotechnology, Inc. ·
NAUT 8-K 2026-09-11
Nautilus Biotechnology, Inc. (NAUT) 8-K dated 2026-09-11 — accession 0001808805-26-000041. This URL is the filing, not the NAUT hub.
Nautilus Biotechnology, Inc. (NAUT) is a biotechnology company listed on US.
Nautilus Biotechnology, Inc. filed a 8-K on 2026-09-11. Accession 0001808805-26-000041.
Cached items: 1.01, 1.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.
Latest reported NAUT revenue for 2026-06-30 was $190.0K. Net income was -$14.5M. NAUT currently screens at market cap $103.4M.
Not investment advice. The NAUT SEC hub lists recent forms. The stock page is the research view.